Carregant...

Sequential and combination treatments with novel agents in chronic lymphocytic leukemia

Chemoimmunotherapy has been the standard of care for patients with chronic lymphocytic leukemia for a long time. However, over the last few years, novel agents have produced unprecedented outcomes in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia. With the advent of these targe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Haematologica
Autors principals: Fürstenau, Moritz, Hallek, Michael, Eichhorst, Barbara
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2019
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6821614/
https://ncbi.nlm.nih.gov/pubmed/31585959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.208603
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!